Proteomic characterization of FBXW7-mutant CRISPR

Awarded Award Notice Posted

Solicitation number
75N92019Q0180
Agency
National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
Awarded
to Cell Signaling Technology, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N92019P00334 Federal contract award
NAICS code
621511 Medical Laboratories
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

Proteomic characterization of FBXW7-mutant CRISPR edited uterine cancer cells. Awarded Vendors: CELL SIGNALING TECHNOLOGY, INC.
3 TRASK LANE
DANVERS
MA
01923
USA. Contract Award Dollar Amount: $148,500.00. Contract Award Date: 2019-08-15.

Update #1 ·

Proteomic characterization of FBXW7-mutant CRISPR edited uterine cancer cells.

Attachments

Files attached to this notice, newest first
File Type Posted
FedConnect File —

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity